RxDoctor Payments Data

Yaroslav Kushnir

Psychiatry · Chula Vista, CANPI 1730274176

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 31.1% of the total. Reporting peaked in 2021 at $950 and has fallen 83.5% since, to $156 in 2022.

$2,241in general payments, 2019–2025

Across 165 payments — averaging $13.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$698
  • Teva Pharmaceuticals USA, Inc.$678
  • Vanda Pharmaceuticals Inc.$441
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$119
  • Noven Therapeutics, LLC$77
  • Alkermes, Inc.$74
  • plus $154 from 6 others

What the payments were for

  • Food & beverage$2,19598%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,241 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in Chula Vista

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →